Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian F McBride

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pharmacology|February 4, 2010
Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxabanJason Morell, Bridgette Sullivan, Marina Khalabuda, et al.
Pacing and Clinical Electrophysiology : PACE|October 6, 2004
Inappropriate implantable cardioverter defibrillator discharge following consumption of a dietary weight loss supplementBrian F McBride, Danette Guertin, C Michael White, et al.
The Annals of Pharmacotherapy|April 24, 2003
Nicardipine to control neonatal hypertension during extracorporeal membrane oxygen supportBrian F McBride, C Michael White, Margaret Campbell, et al.
Journal of Pharmacy Practice|April 22, 2011
A case report of atrial fibrillation potentially induced by hydroxycut: a multicomponent dietary weight loss supplement devoid of sympathomimetic aminesAbigail Karth, Noa Holoshitz, Clifford J Kavinsky, et al.
Pharmacotherapy|June 26, 2010
Drug-induced QT-interval prolongation: considerations for cliniciansEdward C Li, John S Esterly, Shaunte Pohl, et al.
Archives of Internal Medicine|August 11, 2010
Effect of Enzyte on QT and QTc intervalsMark Philips, Mark Phillips, Bridgette Sullivan, et al.
British Journal of Pharmacology|October 28, 2010
Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1Tao Yang, Brian F McBride, Brenda F Leake, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|July 21, 2005
The impact of catecholamines in patients with or without beta-blockers on the ventricular fibrillation cycle length and ventricular fibrillation cycle length variabilityBokyung Min, Jeffrey Kluger, James S Kalus, et al.
JAMA|January 15, 2004
Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trialBrian F McBride, Angeliki K Karapanos, Agnes Krudysz, et al.
Pacing and Clinical Electrophysiology : PACE|December 20, 2005
The impact of catecholamines on defibrillation threshold in patients with implanted cardioverter defibrillatorsJames S Kalus, C Michael White, Michael F Caron, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacology|February 4, 2010
Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxabanJason Morell, Bridgette Sullivan, Marina Khalabuda, et al.
Pacing and Clinical Electrophysiology : PACE|October 6, 2004
Inappropriate implantable cardioverter defibrillator discharge following consumption of a dietary weight loss supplementBrian F McBride, Danette Guertin, C Michael White, et al.
The Annals of Pharmacotherapy|April 24, 2003
Nicardipine to control neonatal hypertension during extracorporeal membrane oxygen supportBrian F McBride, C Michael White, Margaret Campbell, et al.
Journal of Pharmacy Practice|April 22, 2011
A case report of atrial fibrillation potentially induced by hydroxycut: a multicomponent dietary weight loss supplement devoid of sympathomimetic aminesAbigail Karth, Noa Holoshitz, Clifford J Kavinsky, et al.
Pharmacotherapy|June 26, 2010
Drug-induced QT-interval prolongation: considerations for cliniciansEdward C Li, John S Esterly, Shaunte Pohl, et al.
Archives of Internal Medicine|August 11, 2010
Effect of Enzyte on QT and QTc intervalsMark Philips, Mark Phillips, Bridgette Sullivan, et al.
British Journal of Pharmacology|October 28, 2010
Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1Tao Yang, Brian F McBride, Brenda F Leake, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|July 21, 2005
The impact of catecholamines in patients with or without beta-blockers on the ventricular fibrillation cycle length and ventricular fibrillation cycle length variabilityBokyung Min, Jeffrey Kluger, James S Kalus, et al.
JAMA|January 15, 2004
Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trialBrian F McBride, Angeliki K Karapanos, Agnes Krudysz, et al.
Pacing and Clinical Electrophysiology : PACE|December 20, 2005
The impact of catecholamines on defibrillation threshold in patients with implanted cardioverter defibrillatorsJames S Kalus, C Michael White, Michael F Caron, et al.
Pageof 3